Hormonal
Long-acting GLP-1 receptor agonist (Ex-4)2-Fc promotes adipose tissue browning and thermogenesis in high-fat diet mice by enriching gut Lactobacillus reuteri and reducing serum ceramide levels via upregulation of alkaline ceramidase 2 (Acer2).
This research suggests that GLP-1 agonists do more than just suppress appetite; they actively change how fat tissue works by promoting 'browning' (heat production) and improving lipid metabolism. This effect is linked to changes in gut bacteria (specifically Lactobacillus reuteri) and the reduction of harmful lipids called ceramides. For individuals considering GLP-1 therapy, this highlights that the drug works through complex biological pathways beyond just eating less, potentially offering metabolic benefits even at lower doses when combined with healthy gut flora.
we treated high-fat diet mice with GLP-1 RA and demonstrated that the drug can regulate adipose tissue browning... it increased the abundance of bacterium Lactobacillus reuteri and decreased serum ceramide levels in mice... the mechanism of ceramide decline was alkaline ceramidase 2 (Acer2) overexpression.
Why this rating
The study is an animal model (mice) study, not a human clinical trial, limiting direct applicability to humans.
Source
Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism
Ke Lin et al. · MedComm · 2023
DOI 10.1002/mco2.416
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →